Shreechem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 23-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 23-12-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 88.53 Cr
as on 23-12-2024
- Revenue -20.47%
(FY 2019)
- Profit 68.46%
(FY 2019)
- Ebitda 105.72%
(FY 2019)
- Net Worth -41.82%
(FY 2019)
- Total Assets -7.02%
(FY 2019)
About Shreechem Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 5.00 Cr.
The company has closed loans amounting to ₹88.53 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Keyur Mehta and Trilokinath Ram serve as directors at the Company.
- CIN/LLPIN
U24230MH1997PTC105930
- Company No.
105930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shreechem Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Keyur Mehta  | Director | 28-Oct-2022 | Current |
| Trilokinath Ram | Director | 11-Nov-2022 | Current |
Financial Performance of Shreechem Pharmaceuticals.
Shreechem Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 20.47% decrease. The company also saw a substantial improvement in profitability, with a 68.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 41.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shreechem Pharmaceuticals?
Unlock access to Shreechem Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Jun 2015 | ₹3.00 Cr | Satisfied |
Others Creation Date: 27 Mar 2015 | ₹1.50 Cr | Satisfied |
Janata Sahakari Bank Ltd Pune Creation Date: 30 Sep 2014 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Shreechem Pharmaceuticals?
Shreechem Pharmaceuticals has a workforce of 12 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shreechem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreechem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
